In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer-Reference-Cited by-同舟云学术

In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer

Published:2016-06 Issue:1 Volume:16 Page:133-147
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Carugo Alessandro,Genovese Giannicola,Seth Sahil,Nezi Luigi,Rose Johnathon Lynn,Bossi Daniela,Cicalese Angelo,Shah Parantu Krushnakant,Viale Andrea,Pettazzoni Piergiorgio Francesco,Akdemir Kadir Caner,Bristow Christopher Aaron,Robinson Frederick Scott,Tepper James,Sanchez Nora,Gupta Sonal,Estecio Marcos Roberto,Giuliani Virginia,Dellino Gaetano Ivan,Riva Laura,Yao Wantong,Di Francesco Maria Emilia,Green Tessa,D’Alesio Carolina,Corti Denise,Kang Ya’an,Jones Philip,Wang Huamin,Fleming Jason Bates,Maitra Anirban,Pelicci Pier Giuseppe,Chin Lynda,DePinho Ronald Anthony,Lanfrancone Luisa,Heffernan Timothy Paul,Draetta Giulio Francesco

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference63 articles.

1. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes;Almoguera;Cell,1988

2. American Cancer Society. (2015). Cancer Facts & Figures.

3. An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma;Baratta;Proc. Natl. Acad. Sci. USA,2015

4. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes;Biankin;Nature,2012

5. Statistical methods for analysis of high-throughput RNA interference screens;Birmingham;Nat. Methods,2009

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural studies of WDR5 in complex with MBD3C WIN motif reveal a unique binding mode;Journal of Biological Chemistry;2024-07

2. Non-oncogene dependencies: Novel opportunities for cancer therapy;Biochemical Pharmacology;2024-05

3. Clonal dominance defines metastatic dissemination in pancreatic cancer;Science Advances;2024-03-15

4. MYC the oncogene from hell: Novel opportunities for cancer therapy;European Journal of Medicinal Chemistry;2024-03

5. Exploring promising natural compounds for breast cancer treatment: in silico molecular docking targeting WDR5-MYC protein interaction;Journal of Biomolecular Structure and Dynamics;2024-02-14